gsk3228836
Showing 1 - 6 of 6
Hepatitis B Trial in Orlando, San Antonio (GSK3228836)
Recruiting
- Hepatitis B
- GSK3228836
-
Orlando, Florida
- +1 more
Jul 1, 2022
Hepatitis B Trial in Worldwide (GSK3228836, Nucleos(t)ide therapy)
Recruiting
- Hepatitis B
- GSK3228836
- Nucleos(t)ide therapy
-
Boston, Massachusetts
- +3 more
Aug 24, 2022
Hepatitis B Trial in Worldwide (GSK3228836, PegIFN, NA therapy)
Active, not recruiting
- Hepatitis B
- GSK3228836
- +2 more
-
Sacramento, California
- +48 more
Jan 19, 2023
Hepatitis B Trial in Worldwide (GSK3228836)
Recruiting
- Hepatitis B
- GSK3228836
-
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- +40 more
Jul 28, 2022
Hepatitis B, Chronic Trial in Worldwide (GSK3228836, GSK3528869A, Control)
Recruiting
- Hepatitis B, Chronic
- GSK3228836
- +2 more
-
Edegem, Belgium
- +47 more
Jan 24, 2023
Hepatitis B Trial in Worldwide (GSK3228836, Placebo, Nucleos(t)ide therapy)
Completed
- Hepatitis B
- GSK3228836
- +2 more
-
Los Angeles, California
- +120 more
Jul 1, 2022